AUSTIN, Texas, Aug. 22, 2016 /PRNewswire/ -- Celling
Biosciences, the foremost pioneer in point-of-care cell therapies,
is opening an international office in Curitiba, Brazil, one of the largest medical markets in
the world. Combined with Mexican sales that continue to grow,
company leaders are confident that this new office will build a
bright future for cell therapies in all of South America.
The international development team will continue discussions
with Ireland to manage the
European expansion. Celling Dubai's office has yielded information
indicating that cell therapy will be well received in the
Dubai and East Asian markets.
Kevin Dunworth, CEO of Celling
Biosciences, said, "We're very excited about this opportunity, and
the timing could not be better with the world's attention focused
on the athletes in Rio for the Olympics. I personally started my
career internationally in Europe,
the Middle East, and South America. So this is a little like coming
home for me. Though it took more time than I wanted, the
technology we now offer has been well vetted in our own
market, and I'm thrilled to bring it to the international stage in
a place like Brazil."
While the Brazil office will
enter Celling's traditional markets of orthopedics and spine,
company representatives say they are excited to continue developing
their faster growing segments of pain management and cosmesis.
According to Andre Luiz Macias,
managing partner of Celling Brazil, "We are very excited about not
only the sports medicine applications but also believe the
aesthetics opportunity is one of the largest in the world. We have
been working closely with the research and development team in
Austin, Texas to educate ourselves
on the latest technologies for processing and delivering cells to
the patient. Our objective is to take the ongoing effort in the
U.S. and deliver the same education and scientific excellence to
the physicians and patients across Brazil."
Celling Brazil will follow the
North American model of relying heavily upon a team of highly
trained scientists to educate physicians on the ever expanding
potential of autologous cell therapies. The research team has
expressed excitement about the incredible opportunity to do
clinical studies in Brazil across
a wide spectrum of applications including critical limb ischemia,
sports related injuries, and procedures for cosmetic rejuvenation
of the skin.
Celling Biosciences Brazil
Managing Partner:
Andre Luiz Macias
Av. Sete de setembro, 5402 , sala 75
Curitiba - ParanĂ¡ - Brasil
80240-000
Contact:
Steve Melchiode
smelchiode@cellingbiosciences.com
Photo - http://photos.prnewswire.com/prnh/20160819/399667
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/celling-biosciences-opens-international-office-in-brazil-300316539.html
SOURCE Celling Biosciences